Helius Medical Technologies, Inc. , a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma.
Helius Medical Technologies stock last closed at $8.60, down 5.55% from the previous day, and has decreased 98.83% in one year. It has underperformed other stocks in the Medical Devices industry by 0.78 percentage points. Helius Medical Technologies stock is currently +4.69% from its 52-week low of $8.21, and -99.28% from its 52-week high of $1,200.00.
There are currently 10,561 HSDT shares outstanding. The market cap of HSDT is $90.77k. In the last 24 hours, 252,000 HSDT shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy HSDT shares.
Based on our research, eToro is the best place to buy stocks. Here's why:
Get $10 towards your purchase of stock by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've chosen the right brokerage, you'll need to fill out some personal info so you are able to invest in HSDT today.
Now that you've opened your account on a good online stock trading app, you can securely and quickly fund your account:
Watch the tutorial below for more details depositing funds into your investment account.
After you have chosen the best place to buy Helius Medical Technologies stock, it's critical to analyze their stock prior to investing, so you actually wrap your head around the risk and upside.
WallStreetZen was built to help average investors perform more accurate fundamental analysis.
You can view all of the due diligence checks on HSDT's stock page.
You can use many financial metrics, analyses, models, and charts to gauge HSDT's fair value.
Using relative valuations measures:
You can access additional valuation research on HSDT's stock here.
You can dig deeper into what analysts are saying on the Helius Medical Technologies stock forecast page.
Last year, HSDT revenue was $434.00k. Over the past five year, HSDT's revenue has increased by -15.81% per year. This was slower than the Medical Devices industry average of 9.78%.
Learn more about HSDT's earnings and revenue performance here.
In the last year, executives and large shareholders at HSDT have not bought or sold any shares.
Dig into more about who owns HSDT stock here.
No, Helius Medical Technologies doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other traders have to say.
There are two primary types of orders:
Press the Open button and your broker will place the order.
If you require additional assistance investing in stocks on eToro, click the how to video below:
Now that you own some HSDT shares, you'll want to stay up-to-date on your new investment.
Put HSDT on a watchlist to get the latest updates about your HSDT stock.
To summarize, here are the 6 steps you need to take to buy Helius Medical Technologies stock right now:
If you need a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to keep an eye on your new investment in Helius Medical Technologies, click the button below.